LRP6 and pancreatic neoplasm: More specifically, the microRNA miR-454, which targets LRP6 mRNA, is downregulated in PDAC (Figure 3D) and therefore its overexpression in pancreatic cancer cells impairs proliferation, angiogenic activity and metastatic potential [114,115].